Abdominal obesity and insulin resistance in patients with type 2 diabetes in a Swedish community -: Skaraborg Hypertension and Diabetes Project

被引:9
作者
Bari, Muhammad Rizuanul
Ostgren, Carl Johan
Rastam, Lennart
Lindblad, Ulf
机构
[1] Lund Univ, Dept Clin Sci, Malmo, Sweden
[2] Linkoping Univ, Dept Hlth & Soc, Skovde, Sweden
[3] Skaraborg Inst, Skovde, Sweden
关键词
body mass index; family practice; insulin resistance; primary care; type; 2; diabetes; waist circumference;
D O I
10.1080/02813430601035290
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective. To explore the association between abdominal obesity and insulin resistance in patients with type 2 diabetes. Design. A cross-sectional observational study. Setting. Primary care in Skara, Sweden. Subjects. A total of 198 men and 186 women with type 2 diabetes who consecutively completed an annual check-up in 1992-1993. Main outcome measures. Abdominal obesity was defined according to criteria for the metabolic syndrome using the waist circumference (WC): > 102 cm for men and > 88 cm for women. Insulin resistance was estimated using the Homeostasis Model Assessment (HOMA), and was dichotomized by the 75th percentile (IR). Results. Abdominal obesity was found in 66 men (33%), and in 106 women (57%). Pearson's correlation coefficients between components of the metabolic syndrome and IR were statistically significant for WC, waist-hip ratio, serum triglycerides, and HDL cholesterol, and were higher for WC (0.40) than for waist-hip ratio (0.23) in both genders (p < 0.001). The association between WC and IR was challenged by successively entering other components of the metabolic syndrome into the model in a logistic regression. In the final model, adjusting for differences in age, systolic blood pressure, HbA1c, serum triglycerides, HDL cholesterol, and microalbuminuria, the association remained statistically significant both in men (OR 8.6, 95% CI 3.0-25.2, p < 0.001), and in women (OR 5.6, 95% CI 1.7-18.1, p = 0.004). Conclusions. WC provides a feasible measure for insulin resistance in the vast majority of subjects with type 2 diabetes. It is convenient and less expensive than direct means and could be used as a proxy for insulin resistance in population studies.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 31 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]  
ANDERSEN L, 1993, CLIN CHEM, V39, P578
[4]  
Ascaso Juan F, 2003, Eur J Intern Med, V14, P101, DOI 10.1016/S0953-6205(03)00022-0
[5]   Survival in patients with hypertension treated in primary care -: A population-based follow-up study in the Skaraborg Hypertension and Diabetes Project [J].
Bog-Hansen, E ;
Merlo, J ;
Gullberg, B ;
Melander, A ;
Råstam, L ;
Lindblad, U .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2004, 22 (04) :222-227
[6]   HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects - Prospective data from the Verona Diabetes Complicated Study [J].
Bonora, E ;
Formentini, G ;
Calcaterra, F ;
Lombardi, S ;
Marini, F ;
Zenari, L ;
Saggiani, F ;
Poli, M ;
Perbellini, S ;
Raffaelli, A ;
Cacciatori, V ;
Santi, L ;
Targher, G ;
Bonadonna, R ;
Muggeo, M .
DIABETES CARE, 2002, 25 (07) :1135-1141
[7]   OBESITY, FAT DISTRIBUTION, AND WEIGHT-GAIN AS RISK-FACTORS FOR CLINICAL DIABETES IN MEN [J].
CHAN, JM ;
RIMM, EB ;
COLDITZ, GA ;
STAMPFER, MJ ;
WILLETT, WC .
DIABETES CARE, 1994, 17 (09) :961-969
[8]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[9]   WEIGHT-GAIN AS A RISK FACTOR FOR CLINICAL DIABETES-MELLITUS IN WOMEN [J].
COLDITZ, GA ;
WILLETT, WC ;
ROTNITZKY, A ;
MANSON, JE .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (07) :481-486
[10]  
Daniel M, 1999, AM J CLIN NUTR, V69, P455